Biotech · Private company
Oxurion
Track this companyFree. Adds Oxurion to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- AfliberceptPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- aflibercept 2mg + THR-149 0.13mgPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-149 0.13mgPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-149 0.13mg + aflibercept 2mgPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-149 dose level 1Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-149 dose level 2Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-149 dose level 3Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-687 dose level 1Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-687 dose level 2Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- THR-687 selected dose levelPhase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.PHASE2 · TERMINATED · started Aug 27, 2021ClinicalTrials.gov NCT05063734 · fetched Nov 12, 2026
- A Study to Evaluate THR-149 Treatment for Diabetic Macular OedemaPHASE2 · COMPLETED · started Jul 31, 2020ClinicalTrials.gov NCT04527107 · fetched Nov 12, 2026